Difficulty: Medium
Average Score: 93%
Practice
Muscarinic receptors can be stimulated by the following drugs EXCEPT:
Correct answer
B
Rationale
In this question, the correct answer is B) Hyoscine. To understand why Hyoscine does not stimulate muscarinic receptors, we need to look at its pharmacological properties. Hyoscine, also known as scopolamine, is an anticholinergic drug that acts as a competitive antagonist at muscarinic receptors. This means it blocks the action of acetylcholine at these receptors rather than stimulating them.
On the other hand, options A, C, and D all have the ability to stimulate muscarinic receptors. Pilocarpine (A) is a direct-acting cholinergic agonist that specifically targets muscarinic receptors, leading to their stimulation. Acetylcholine (C) is the endogenous neurotransmitter that acts on muscarinic receptors in the parasympathetic nervous system. Neostigmine (D) is an indirect-acting cholinergic agonist that inhibits the enzyme acetylcholinesterase, leading to an increase in acetylcholine levels and subsequent stimulation of muscarinic receptors.
In an educational context, understanding the pharmacology of drugs that interact with the peripheral nervous system is crucial for healthcare professionals such as nurses, pharmacists, and physicians. Knowing which drugs stimulate or block muscarinic receptors helps in clinical decision-making, especially in managing conditions like glaucoma, urinary retention, and myasthenia gravis where modulation of cholinergic activity is essential. By grasping these concepts, healthcare providers can optimize patient care and minimize adverse effects associated with peripheral nervous system drugs.
On the other hand, options A, C, and D all have the ability to stimulate muscarinic receptors. Pilocarpine (A) is a direct-acting cholinergic agonist that specifically targets muscarinic receptors, leading to their stimulation. Acetylcholine (C) is the endogenous neurotransmitter that acts on muscarinic receptors in the parasympathetic nervous system. Neostigmine (D) is an indirect-acting cholinergic agonist that inhibits the enzyme acetylcholinesterase, leading to an increase in acetylcholine levels and subsequent stimulation of muscarinic receptors.
In an educational context, understanding the pharmacology of drugs that interact with the peripheral nervous system is crucial for healthcare professionals such as nurses, pharmacists, and physicians. Knowing which drugs stimulate or block muscarinic receptors helps in clinical decision-making, especially in managing conditions like glaucoma, urinary retention, and myasthenia gravis where modulation of cholinergic activity is essential. By grasping these concepts, healthcare providers can optimize patient care and minimize adverse effects associated with peripheral nervous system drugs.